Polio laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:
If [[poliovirus]] is isolated from a person with acute [[flaccid paralysis]], or if it occurs in an area where there is low [[incidence]] of the disease, it must be further tested in order to assess the source of the virus.  The virus may be "wild-type" (occurs naturally) or vaccine related (OPV or cVDPV).<ref name=CDC>{{cite web | title = Poliomyelitis | url = http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#epi }}</ref><ref>{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>  The characterization of the source of the virus may be achieved by [[genomic]] sequencing.<ref name="KewMulders1995">{{cite journal|last1=Kew|first1=Olen M.|last2=Mulders|first2=Mick N.|last3=Lipskaya|first3=Galina Yu.|last4=da Silva|first4=Edson E.|last5=Patlansch|first5=Mark A.|title=Molecular epidemiology of polioviruses|journal=Seminars in Virology|volume=6|issue=6|year=1995|pages=401–414|issn=10445773|doi=10.1016/S1044-5773(05)80017-4}}</ref><ref>{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>
If [[poliovirus]] is isolated from a person with acute [[flaccid paralysis]], or if it occurs in an area where there is low [[incidence]] of the disease, it must be further tested in order to assess the source of the virus.  The virus may be "wild-type" (occurs naturally) or vaccine related (OPV or cVDPV).<ref name=CDC>{{cite web | title = Poliomyelitis | url = http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#epi }}</ref><ref>{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>  The characterization of the source of the virus may be achieved by [[genomic]] sequencing.<ref name="KewMulders1995">{{cite journal|last1=Kew|first1=Olen M.|last2=Mulders|first2=Mick N.|last3=Lipskaya|first3=Galina Yu.|last4=da Silva|first4=Edson E.|last5=Patlansch|first5=Mark A.|title=Molecular epidemiology of polioviruses|journal=Seminars in Virology|volume=6|issue=6|year=1995|pages=401–414|issn=10445773|doi=10.1016/S1044-5773(05)80017-4}}</ref><ref>{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>


===Cerebrospinal Fluid===
In poliovirus infection, the CSF usually contains an increased number of white blood cells (10–200 cells/mm3, primarily lymphocytes) and a mildly elevated protein (40–50 mg/100 mL).<ref name=CDC>{{cite web | title = Poliomyelitis | url = http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#epi }}</ref>  However, these findings are similar to those of aseptic meningitis caused by other viruses.
The isolation of poliovirus from the CSF, is particularly important in cases of paralytic poliomyelitis following administration of the vaccine.  Since viral shedding through feces occurs during several weeks after the person has been vaccinated, isolation of the virus in the CNS and its characterization as "wild-type" or "vaccine related" is the only way of proving an association between the disease and the vaccine.<ref>{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>


===Serology===
===Serology===
Neutralizing antibodies appear early and may be at high levels by the time the patient is hospitalized; therefore, a fourfold rise in antibody titer may not be demonstrated.<ref name=CDC>{{cite web | title = Poliomyelitis | url = http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#epi }}</ref>
If the virus cannot be isolated, the the diagnosis of poliomyelitis may be established serologically.  Serology tests may be performed in acute serum and convalescent serum, with neutralizing antibodies, targeted for all three serotypes of the virus.  However, serologic tests cannot distinguish between the "wild-type" and "vaccine-type" of poliovirus.<ref>{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>


===Cerebrospinal Fluid===
In poliovirus infection, the CSF usually contains an increased number of white blood cells (10–200 cells/mm3, primarily lymphocytes) and a mildly elevated protein (40–50 mg/100 mL).<ref name=CDC>{{cite web | title = Poliomyelitis | url = http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#epi }}</ref>  However, these findings are similar to those of aseptic meningitis caused by other viruses.


The isolation of poliovirus from the CSF, is particularly important in cases of paralytic poliomyelitis following administration of the vaccine.  Since viral shedding through feces occurs during several weeks after the person has been vaccinated, isolation of the virus in the CNS and its characterization as "wild-type" or "vaccine related" is the only way of proving an association between the disease and the vaccine.<ref>{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>
Neutralizing antibodies appear early and may be at high levels by the time the patient is hospitalized; therefore, a fourfold rise in antibody titer may not be demonstrated.<ref name=CDC>{{cite web | title = Poliomyelitis | url = http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#epi }}</ref>


In the absence of a viral isolate, the diagnosis of poliovirus infection can be established serologically by testing paired acute and convales- cent sera for neutralizing antibodies to each of the three poliovirus serotypes. Serologic tests cannot distinguish between wild-type virus and vaccine virus infection.
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 15:56, 3 September 2014

Polio Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Poliovirus

Differentiating Polio from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Case Studies

Case #1

Polio laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polio laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polio laboratory findings

CDC on Polio laboratory findings

Polio laboratory findings in the news

Blogs on Polio laboratory findings

Directions to Hospitals Treating Polio

Risk calculators and risk factors for Polio laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Laboratory Findings

Viral Isolation

Poliovirus may be isolated from pharyngeal secretions during the first week of the disease, and from feces during several weeks. Isolation of virus from the cerebrospinal fluid (CSF) is diagnostic, however this is rarely accomplished.[1][2]

If poliovirus is isolated from a person with acute flaccid paralysis, or if it occurs in an area where there is low incidence of the disease, it must be further tested in order to assess the source of the virus. The virus may be "wild-type" (occurs naturally) or vaccine related (OPV or cVDPV).[1][3] The characterization of the source of the virus may be achieved by genomic sequencing.[4][5]

Cerebrospinal Fluid

In poliovirus infection, the CSF usually contains an increased number of white blood cells (10–200 cells/mm3, primarily lymphocytes) and a mildly elevated protein (40–50 mg/100 mL).[1] However, these findings are similar to those of aseptic meningitis caused by other viruses.

The isolation of poliovirus from the CSF, is particularly important in cases of paralytic poliomyelitis following administration of the vaccine. Since viral shedding through feces occurs during several weeks after the person has been vaccinated, isolation of the virus in the CNS and its characterization as "wild-type" or "vaccine related" is the only way of proving an association between the disease and the vaccine.[6]

Serology

If the virus cannot be isolated, the the diagnosis of poliomyelitis may be established serologically. Serology tests may be performed in acute serum and convalescent serum, with neutralizing antibodies, targeted for all three serotypes of the virus. However, serologic tests cannot distinguish between the "wild-type" and "vaccine-type" of poliovirus.[7]


Neutralizing antibodies appear early and may be at high levels by the time the patient is hospitalized; therefore, a fourfold rise in antibody titer may not be demonstrated.[1]

References

  1. 1.0 1.1 1.2 1.3 "Poliomyelitis".
  2. Mandell, Gerald (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 0443068399.
  3. Mandell, Gerald (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 0443068399.
  4. Kew, Olen M.; Mulders, Mick N.; Lipskaya, Galina Yu.; da Silva, Edson E.; Patlansch, Mark A. (1995). "Molecular epidemiology of polioviruses". Seminars in Virology. 6 (6): 401–414. doi:10.1016/S1044-5773(05)80017-4. ISSN 1044-5773.
  5. Mandell, Gerald (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 0443068399.
  6. Mandell, Gerald (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 0443068399.
  7. Mandell, Gerald (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 0443068399.

Template:WH Template:WS